forecast glp-1 prescriptions growth 2025 semaglutide tirzepatide Weight Loss Drug Market Size, Share The United States GLP-1 Agonists

Rybelsus is not licensed for use as a weight loss medicine, but its active ingredient semaglutide, has been shown to help control appetite by reducing cravings and keeping people feeling fuller for longer

What factors determine the value of an Ozempic blood clot lawsuit

Injectable use is off-label and not reimbursable

PlexusDx's compounded tirzepatide injection is $289/mo month-to-month, or from $249/mo on the 6-month plan, making it 60% to 75% more affordable than typical insurance copays for brand-name formulations

All treatments are HSA/FSA eligible and available in all 50 states

if they miss multiple doses due to timing challenges